文献速递糖尿病

2001-2018年美国老年糖尿病患者对美国糖尿病协会血糖目标的依从性

Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018.
PubMed 文献 · Diabetes Care · 2022-01-01

该研究基于2001-2018年美国国家健康与营养调查(NHANES)的横断面分析,纳入3,539例≥65岁糖尿病患者,按健康状况分为良好、中等和差。结果显示平均HbA1c随时间上升且不因健康状况而异;用药率从59%升至74%;健康状况差且用药的患者中约一半HbA1c低于目标,三分之二使用与低血糖相关的药物;健康状况差且低于目标的患者接受低血糖相关药物的校正比值比为4.9(95%CI 2.3-10.4)。

要点

  • 平均HbA1c随时间上升,且不因健康状况而异。
  • 用药率从59%升至74%,健康状况差者常用磺脲类和胰岛素。
  • 健康状况差且用药者中约一半HbA1c低于目标,三分之二使用低血糖相关药物。

核心结论

  • 根据ADA较新的糖尿病医疗照护标准,HbA1c目标有所放宽,但未因健康状况而异。
  • 健康状况差的患者中HbA1c低于目标常见,许多人被处方与较高低血糖风险相关的药物。

研究设计与样本

  • 研究为2001-2018年美国国家健康与营养调查(NHANES)的横断面分析。
  • 纳入≥65岁、曾被诊断为糖尿病、HbA1c>6.4%或空腹血糖>125 mg/dL的老年人,共3,539例。
  • 健康状况分为良好、中等和差;低于目标定义为用药且HbA1c≥1%低于ADA血糖目标(目标随健康状况和时间段变化)。

主要发现

  • 平均HbA1c随时间上升,且不因健康状况而异。
  • 用药率从59%升至74%;健康状况良好或中等者最常用二甲双胍,健康状况差者最常用磺脲类和胰岛素。
  • 用药患者中,低于目标的患病率上升,高于目标的患病率从2001年至2018年下降。
  • 健康状况差且用药的患者中,一半HbA1c低于目标,三分之二使用与低血糖相关的药物。
  • 健康状况差且低于目标的患者接受与低血糖相关药物的校正比值比为4.9(95%CI 2.3-10.4),高于健康患者。

关键数值与推荐

  • 低于目标定义为用药且HbA1c≥1%低于ADA血糖目标,目标随患者健康状况和时间段变化。
  • 与低血糖相关的药物包括磺脲类、胰岛素和格列奈类。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess trends in HbA1c and appropriateness of diabetes medication use by patient health status. RESEARCH DESIGN AND METHODS: We conducted cross-sectional analysis of 2001-2018 National Health and Nutrition Examination Survey (NHANES). We included older adults age ≥65 years who had ever been told they had diabetes, had HbA1c >6.4%, or had fasting plasma glucose >125 mg/dL. Health status was categorized as good, intermediate, or poor. Being below goal was defined as taking medication despite having HbA1c ≥1% below the glycemic goals of the American Diabetes Association (ADA), which varied by patient health status and time period. Drugs associated with hypoglycemia included sulfonylureas, insulin, and meglitinides. RESULTS: We included 3,539 patients. Mean HbA1c increased over time and did not differ by health status. Medication use increased from 59% to 74% with metformin being the most common drug in patients with good or intermediate health and sulfonylureas and insulin most often prescribed to patients with poor health. Among patients taking medications, prevalence of patients below goal increased while prevalence of those above goal decreased from 2001 to 2018. One-half of patients with poor health and taking medications had below-goal HbA1c; two-thirds received drugs associated with hypoglycemia. Patients with poor health who were below goal had 4.9 (95% CI 2.3-10.4) times the adjusted odds of receiving drugs associated with hypoglycemia than healthy patients. CONCLUSIONS: In accordance with ADA's newer Standards of Medical Care in Diabetes, HbA1c goals were relaxed but did not differ by health status. Below-goal HbA1c was common among patients with poor health; many were prescribed medications associated with a higher risk of hypoglycemia.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Le P, Ayers G, Misra-Hebert AD, et al. Adherence to the American Diabetes Association's Glycemic Goals in the Treatment of Diabetes Among Older Americans, 2001-2018. Diabetes Care. 2022. PMID: 35076695. doi:10.2337/dc21-1507

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。